Minimally invasive thoracic surgery (MITS) is reshaping the management of lung cancer, mediastinal disorders, pleural disease, esophageal conditions, pneumothorax, and benign thoracic pathology by reducing surgical trauma while preserving clinical effectiveness. The field spans video-assisted thoracoscopic surgery (VATS), robotic-assisted thoracic surgery (RATS), uniportal approaches, subxiphoid access, navigational bronchoscopy-assisted resection, enhanced imaging, and advanced energy and stapling technologies. Its adoption is supported by peer-reviewed evidence showing that minimally invasive approaches are commonly associated with shorter hospital stays, lower perioperative pain, faster functional recovery, fewer wound-related complications, and improved postoperative pulmonary preservation when compared with conventional open thoracotomy in appropriately selected patients. Demand is reinforced by rising lung cancer screening activity, a high burden of chronic respiratory disease, aging populations with higher surgical risk, and health-system pressure to improve operating room efficiency and reduce avoidable inpatient utilization. As thoracic programs expand, clinical excellence increasingly depends on multidisciplinary case selection, surgeon training, standardized perioperative pathways, and investment in imaging, anesthesia, instrumentation, and digital surgical planning.

Transformative Shifts in the Minimally Invasive Thoracic Surgery Landscape

The minimally invasive thoracic surgery landscape is moving from procedure-specific innovation toward integrated, digitally enabled care pathways. VATS remains a widely established platform for lobectomy, segmentectomy, wedge resection, thymectomy, pleural procedures, and sympathectomy, while robotic-assisted systems are gaining clinical relevance for complex dissections, suturing, and lymph node assessment due to enhanced dexterity, tremor filtration, three-dimensional visualization, and ergonomic advantages. A major shift is the rise of lung-sparing anatomical resections, particularly segmentectomy, supported by growing evidence and guideline recognition for selected early-stage non-small cell lung cancer cases. This has increased the importance of high-resolution computed tomography, three-dimensional reconstruction, intersegmental plane identification, fluorescence imaging, and precise nodule localization. Another transformative change is the convergence of diagnostics and therapy, with advanced bronchoscopy, cone-beam CT, electromagnetic or robotic navigation, and image-guided localization helping surgeons manage smaller and deeper pulmonary nodules detected through screening. Enhanced recovery after surgery protocols are also changing clinical economics by prioritizing opioid-sparing analgesia, early mobilization, chest-tube optimization, and faster discharge. At the same time, the specialty is addressing persistent barriers, including capital investment, unequal access to advanced platforms, learning-curve variability, reimbursement complexity, and the need for structured credentialing.

Cumulative Impact of Artificial Intelligence on Minimally Invasive Thoracic Surgery

Artificial intelligence is becoming a cumulative force across the minimally invasive thoracic surgery continuum, from screening and diagnosis to operative planning, intraoperative guidance, and postoperative surveillance. In lung cancer pathways, AI-enabled image analysis supports nodule detection, volumetric tracking, malignancy risk stratification, and workflow prioritization in radiology, helping clinicians manage growing imaging volumes created by low-dose CT screening programs. In surgical planning, machine learning and computer vision can assist with three-dimensional reconstruction, vascular and bronchial mapping, fissure assessment, and simulation-based rehearsal for anatomical resections. During procedures, AI is increasingly relevant for instrument tracking, surgical phase recognition, real-time decision support, automated documentation, and quality assessment, although clinical deployment requires rigorous validation, interoperability, cybersecurity, and human oversight. AI-enhanced robotics and digital platforms may improve consistency in complex minimally invasive thoracic procedures, but the strongest near-term value is likely to come from decision-support tools that reduce variability in patient selection, complication prediction, operating room scheduling, and recovery management. Responsible integration of AI requires transparent algorithms, representative datasets, bias monitoring, regulatory compliance, and clinician training so that automation strengthens, rather than replaces, surgical judgment.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

In Asia-Pacific, demand for minimally invasive thoracic surgery is supported by a high lung cancer burden in several countries, expanding cancer screening initiatives, growing tertiary hospital capacity, and rapid adoption of robotic and thoracoscopic techniques in advanced urban centers. China, Japan, South Korea, India, Australia, and Southeast Asian countries are strengthening thoracic oncology pathways through imaging access, multidisciplinary tumor boards, and training programs, though access remains uneven between metropolitan and rural settings. North America is characterized by mature minimally invasive thoracic surgery programs, broad use of VATS and robotic approaches, established lung cancer screening recommendations for high-risk populations, and strong emphasis on enhanced recovery and outpatient-oriented care where clinically appropriate. Latin America is seeing gradual expansion of minimally invasive thoracic procedures in major referral hospitals, with Brazil and Mexico acting as important clinical hubs; however, equipment affordability, specialist availability, and payer coverage continue to influence access. Europe benefits from guideline-driven cancer care, high participation in professional training networks, and strong public health systems that support standardized thoracic oncology services, although adoption patterns differ across Western, Southern, Central, and Eastern Europe. The Middle East is investing in specialized surgical centers, oncology infrastructure, and medical education, particularly in higher-income health systems, while Africa faces major constraints related to late diagnosis, limited specialist density, and restricted access to advanced operating platforms, even as regional centers develop capabilities in thoracic surgery and cancer care.

Key Group Insights for ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN is becoming increasingly relevant for minimally invasive thoracic surgery as Singapore, Thailand, Malaysia, Vietnam, Indonesia, and the Philippines expand thoracic oncology and advanced surgical services, with regional variation driven by hospital infrastructure, workforce training, and insurance coverage. The GCC is accelerating adoption through investments in high-acuity hospitals, cancer centers, robotic surgery programs, and international clinical collaboration, with a focus on reducing outbound medical travel and improving domestic specialty care. The European Union supports minimally invasive thoracic surgery through harmonized medical device regulation, cross-border clinical research, cancer screening initiatives, and professional education, although reimbursement and procurement mechanisms remain country-specific. BRICS countries represent a diverse set of opportunities and constraints: China and India have large patient populations and expanding surgical capacity, Brazil and South Africa serve as regional referral anchors, and Russia maintains advanced thoracic capabilities in major cities while facing geographic access challenges. The G7 includes several of the world's most established thoracic surgery ecosystems, with strong adoption of evidence-based cancer pathways, advanced imaging, robotic platforms, and clinical quality improvement initiatives. NATO member countries overlap with many high-income European and North American systems where military and civilian medical innovation, trauma experience, digital health infrastructure, and advanced surgical training can support procedural standardization and resilience in specialized thoracic care.

Key Country Insights Across Major Minimally Invasive Thoracic Surgery Markets

The United States has one of the most developed minimally invasive thoracic surgery environments, supported by lung cancer screening guidance, specialized cancer centers, robotic and VATS expertise, and enhanced recovery protocols. Canada emphasizes equitable access within publicly funded healthcare systems, with advanced thoracic surgery concentrated in major academic and regional referral centers. Mexico is expanding minimally invasive thoracic capabilities in private and public tertiary hospitals, particularly in large urban areas, while access differs by geography and payer type. Brazil is Latin America's key thoracic surgery hub, with strong academic expertise and growing use of VATS and robotic approaches in major centers, although resource distribution remains uneven. The United Kingdom benefits from national cancer pathways, thoracic surgery networks, and multidisciplinary care, with minimally invasive approaches integrated into lung cancer treatment for suitable patients. Germany has extensive hospital infrastructure, advanced surgical training, and broad use of endoscopic and robotic techniques in high-volume centers. France combines strong public hospital networks with oncology-focused care coordination, supporting minimally invasive procedures for lung and mediastinal disease. Russia has advanced thoracic surgery capacity in leading metropolitan institutions, while distance and regional infrastructure affect access outside major cities. Italy and Spain maintain strong thoracic surgery traditions, with VATS and robotic programs present in major academic and cancer hospitals. China is rapidly scaling minimally invasive thoracic surgery, supported by large case volumes, domestic clinical research, expanding robotic adoption, and increasing focus on early lung cancer detection. India is advancing through tertiary hospitals, private specialty centers, and growing surgeon training, but affordability and uneven infrastructure remain key constraints. Japan has long-standing expertise in thoracoscopic surgery, early lung cancer management, and technology-enabled precision procedures. Australia operates through specialized thoracic units with strong guideline-based care and screening policy development. South Korea is recognized for high adoption of minimally invasive and robotic thoracic techniques, strong cancer care infrastructure, and advanced digital health capabilities.

Actionable Recommendations for Minimally Invasive Thoracic Surgery Leaders

Industry leaders should prioritize evidence-led adoption rather than technology-led purchasing by aligning minimally invasive thoracic surgery investments with clinical indications, procedural volume, surgeon proficiency, and measurable patient outcomes. Hospitals and surgical networks should build structured training pathways that include simulation, proctorship, dual-console or team-based learning where available, and competency assessment for VATS, robotic-assisted surgery, and advanced bronchoscopy-linked workflows. Decision-makers should standardize enhanced recovery protocols, pain management, chest drainage strategies, and discharge criteria to reduce variation across thoracic programs. To support precision surgery, leaders should invest in integrated imaging, three-dimensional planning, nodule localization, fluorescence guidance, and interoperable data systems that connect radiology, pulmonology, anesthesia, pathology, oncology, and surgery. AI adoption should begin with validated use cases such as imaging workflow support, risk stratification, documentation, and quality analytics, accompanied by governance for bias, privacy, cybersecurity, and clinical accountability. Procurement teams should evaluate total procedural value, including instrument utilization, maintenance, training, operating room time, complication reduction, and pathway efficiency. Finally, health systems should expand access through hub-and-spoke referral models, tele-mentoring, regional training collaboratives, and outcome registries that track safety, equity, and long-term oncologic performance.

Research Methodology

This executive summary is developed using a structured secondary research approach grounded in verified clinical, regulatory, epidemiological, and healthcare-system sources. The methodology emphasizes peer-reviewed surgical literature, clinical practice guidelines, public health publications, cancer registry information, screening recommendations, medical device regulatory references, hospital pathway evidence, and consensus statements from recognized thoracic surgery, oncology, pulmonology, radiology, and anesthesia communities. Evidence was assessed for clinical relevance, recency, reproducibility, and applicability across procedure types such as VATS, robotic-assisted thoracic surgery, segmentectomy, lobectomy, mediastinal surgery, pleural procedures, and diagnostic-to-therapeutic lung nodule workflows. Regional, group, and country insights were synthesized from publicly available healthcare infrastructure indicators, cancer care policies, surgical capacity patterns, technology adoption signals, and access-related evidence without using market sizing, market share, or forecasting assumptions. The analysis avoids unsupported claims and distinguishes established clinical practice from emerging innovation, particularly in AI-enabled imaging, robotic surgery, and digital decision support. Findings are presented as an executive synthesis to support strategic decision-making, technology assessment, clinical program development, and policy-aware planning.

Conclusion

Minimally invasive thoracic surgery has become a central component of modern thoracic care, driven by the need for safer procedures, faster recovery, precision cancer treatment, and efficient healthcare delivery. The field is advancing through the combined impact of VATS, robotic-assisted surgery, advanced imaging, lung-sparing resections, enhanced recovery protocols, and AI-supported decision-making. Adoption is strongest where specialist training, multidisciplinary pathways, imaging infrastructure, and reimbursement alignment are well established, while disparities persist across regions with limited access to technology and thoracic expertise. The next phase of progress will depend on balancing innovation with evidence, expanding workforce capability, strengthening outcome measurement, and ensuring that digital tools and robotic platforms deliver clinically meaningful value. Organizations that invest in standardized care pathways, validated AI applications, advanced visualization, and equitable access models will be best positioned to improve outcomes in lung cancer and other thoracic diseases while supporting sustainable surgical transformation.

Product Code: MRR-3A2E844FEF43

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Minimally Invasive Thoracic Surgery Market, by Procedure Type

7.1. Introduction
7.2. Lung Resection
- 7.2.1. Lobectomy
- 7.2.2. Segmentectomy
- 7.2.3. Wedge Resection
- 7.2.4. Pneumonectomy
- 7.2.5. Lung Volume Reduction Surgery
7.3. Esophageal Procedures
- 7.3.1. Esophagectomy
- 7.3.2. Anti-Reflux Surgery
- 7.3.3. Myotomy
7.4. Mediastinal Procedures
- 7.4.1. Thymectomy
- 7.4.2. Mediastinal Tumor Resection
- 7.4.3. Lymph Node Dissection
7.5. Pleural Procedures
- 7.5.1. Pleurodesis
- 7.5.2. Decortication
- 7.5.3. Bullectomy
- 7.5.4. Pleural Biopsy
7.6. Sympathetic Procedures

8. Minimally Invasive Thoracic Surgery Market, by Product Type

8.1. Introduction
8.2. Surgical Systems
- 8.2.1. Thoracoscopic Video Systems
- 8.2.2. Robotic Surgical Platforms
8.3. Surgical Instruments
- 8.3.1. Endoscopic Hand Instruments
- 8.3.2. Endoscopic Stapling Devices
- 8.3.3. Energy Devices
  - 8.3.3.1. Electrosurgical Devices
  - 8.3.3.2. Ultrasonic Devices
  - 8.3.3.3. Advanced Bipolar Devices
- 8.3.4. Suction-Irrigation Devices
8.4. Access Devices
- 8.4.1. Trocars & Ports
- 8.4.2. Access Needles
- 8.4.3. Wound Protectors
8.5. Closure & Hemostasis Products
- 8.5.1. Sutures & Clips
- 8.5.2. Staple Line Reinforcement Materials
- 8.5.3. Sealants & Hemostatic Agents
8.6. Imaging & Navigation
- 8.6.1. Intraoperative Imaging Systems
- 8.6.2. Fluorescence Imaging Systems
- 8.6.3. Navigation & Mapping Systems

9. Minimally Invasive Thoracic Surgery Market, by Indication

9.1. Introduction
9.2. Malignant Thoracic Diseases
- 9.2.1. Primary Lung Cancer
  - 9.2.1.1. Early-Stage Non-Small Cell Lung Cancer
  - 9.2.1.2. Locally Advanced Non-Small Cell Lung Cancer
- 9.2.2. Metastatic Lung Lesions
- 9.2.3. Esophageal Cancer
- 9.2.4. Mediastinal Malignancies
9.3. Benign Thoracic Diseases
- 9.3.1. Pneumothorax
- 9.3.2. Empyema
- 9.3.3. Benign Esophageal Disorders
  - 9.3.3.1. Gastroesophageal Reflux Disease
  - 9.3.3.2. Achalasia
- 9.3.4. Mediastinal Cysts And Benign Tumors
- 9.3.5. Hyperhidrosis
- 9.3.6. Benign Pulmonary Nodules

10. Minimally Invasive Thoracic Surgery Market, by End User

10.1. Introduction
10.2. Hospitals
- 10.2.1. Tertiary Care Hospitals
- 10.2.2. Community Hospitals
- 10.2.3. Specialty Thoracic Centers
10.3. Ambulatory Surgical Centers
10.4. Specialty Clinics
10.5. Academic And Research Institutes

11. Minimally Invasive Thoracic Surgery Market, by Region

11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa

12. Minimally Invasive Thoracic Surgery Market, by Group

12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO

13. Minimally Invasive Thoracic Surgery Market, by Country

13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea

14. Competitive Landscape

14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
- 14.3.1. Concentration Ratio (CR)
- 14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025

15. Company Profiles

15.1. B. Braun Melsungen AG
15.2. Becton, Dickinson and Company
15.3. Boston Scientific Corporation
15.4. Cardio Medical GmbH
15.5. CONMED Corporation
15.6. Cook Medical LLC
15.7. Dextera Surgical, Inc.
15.8. Fujifilm Holdings Corporation
15.9. GE HealthCare, Inc.
15.10. Grena Ltd.
15.11. Intuitive Surgical, Inc.
15.12. Johnson & Johnson
15.13. KARL STORZ SE & Co. KG
15.14. Koninklijke Philips N.V.
15.15. LivaNova plc
15.16. Medela Healthcare
15.17. Medtronic plc
15.18. Merit Medical Systems, Inc.
15.19. Olympus Corporation
15.20. Sklar Surgical Instruments
15.21. Smith & Nephew plc
15.22. Stryker Corporation
15.23. Teleflex Incorporated
15.24. Terumo Corporation

Product Code: MRR-3A2E844FEF43

LIST OF FIGURES

FIGURE 1. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

TABLE 1. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL LUNG RESECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL LUNG RESECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL LUNG RESECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL LOBECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL LOBECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL LOBECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SEGMENTECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SEGMENTECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SEGMENTECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL WEDGE RESECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL WEDGE RESECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL WEDGE RESECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PNEUMONECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PNEUMONECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PNEUMONECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL LUNG VOLUME REDUCTION SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL LUNG VOLUME REDUCTION SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL LUNG VOLUME REDUCTION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ESOPHAGEAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ESOPHAGEAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ESOPHAGEAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ESOPHAGECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ESOPHAGECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ESOPHAGECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANTI-REFLUX SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANTI-REFLUX SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANTI-REFLUX SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MYOTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MYOTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MYOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MEDIASTINAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MEDIASTINAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MEDIASTINAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL THYMECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL THYMECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL THYMECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MEDIASTINAL TUMOR RESECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MEDIASTINAL TUMOR RESECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MEDIASTINAL TUMOR RESECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL LYMPH NODE DISSECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL LYMPH NODE DISSECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL LYMPH NODE DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PLEURAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PLEURAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PLEURAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PLEURODESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PLEURODESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PLEURODESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DECORTICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DECORTICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DECORTICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BULLECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BULLECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BULLECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PLEURAL BIOPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PLEURAL BIOPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PLEURAL BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SYMPATHETIC PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SYMPATHETIC PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SYMPATHETIC PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SURGICAL SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SURGICAL SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL SURGICAL SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL THORACOSCOPIC VIDEO SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL THORACOSCOPIC VIDEO SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL THORACOSCOPIC VIDEO SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ROBOTIC SURGICAL PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ROBOTIC SURGICAL PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ROBOTIC SURGICAL PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ENDOSCOPIC HAND INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ENDOSCOPIC HAND INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ENDOSCOPIC HAND INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ENDOSCOPIC STAPLING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ENDOSCOPIC STAPLING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ENDOSCOPIC STAPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ENERGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ENERGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ENERGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ELECTROSURGICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ELECTROSURGICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ELECTROSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ULTRASONIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ULTRASONIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ULTRASONIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ADVANCED BIPOLAR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ADVANCED BIPOLAR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ADVANCED BIPOLAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL SUCTION-IRRIGATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL SUCTION-IRRIGATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL SUCTION-IRRIGATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ACCESS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ACCESS DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL TROCARS & PORTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL TROCARS & PORTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL TROCARS & PORTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ACCESS NEEDLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ACCESS NEEDLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ACCESS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL WOUND PROTECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL WOUND PROTECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL WOUND PROTECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL CLOSURE & HEMOSTASIS PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL CLOSURE & HEMOSTASIS PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CLOSURE & HEMOSTASIS PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL SUTURES & CLIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL SUTURES & CLIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL SUTURES & CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL STAPLE LINE REINFORCEMENT MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL STAPLE LINE REINFORCEMENT MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL STAPLE LINE REINFORCEMENT MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL SEALANTS & HEMOSTATIC AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL SEALANTS & HEMOSTATIC AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL SEALANTS & HEMOSTATIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL IMAGING & NAVIGATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL IMAGING & NAVIGATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL IMAGING & NAVIGATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL INTRAOPERATIVE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL INTRAOPERATIVE IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL INTRAOPERATIVE IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL NAVIGATION & MAPPING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL NAVIGATION & MAPPING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL NAVIGATION & MAPPING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL MALIGNANT THORACIC DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL MALIGNANT THORACIC DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL MALIGNANT THORACIC DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL PRIMARY LUNG CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL PRIMARY LUNG CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL PRIMARY LUNG CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL EARLY-STAGE NON-SMALL CELL LUNG CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL EARLY-STAGE NON-SMALL CELL LUNG CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL EARLY-STAGE NON-SMALL CELL LUNG CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL METASTATIC LUNG LESIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL METASTATIC LUNG LESIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL METASTATIC LUNG LESIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL ESOPHAGEAL CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL ESOPHAGEAL CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL ESOPHAGEAL CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL MEDIASTINAL MALIGNANCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL MEDIASTINAL MALIGNANCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL MEDIASTINAL MALIGNANCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL BENIGN THORACIC DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL BENIGN THORACIC DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL BENIGN THORACIC DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL PNEUMOTHORAX MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL PNEUMOTHORAX MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL PNEUMOTHORAX MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL EMPYEMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL EMPYEMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL EMPYEMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL BENIGN ESOPHAGEAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL BENIGN ESOPHAGEAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL BENIGN ESOPHAGEAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL ACHALASIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL ACHALASIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL ACHALASIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL MEDIASTINAL CYSTS AND BENIGN TUMORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL MEDIASTINAL CYSTS AND BENIGN TUMORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL MEDIASTINAL CYSTS AND BENIGN TUMORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL HYPERHIDROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL HYPERHIDROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL HYPERHIDROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL BENIGN PULMONARY NODULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL BENIGN PULMONARY NODULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL BENIGN PULMONARY NODULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL TERTIARY CARE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL TERTIARY CARE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL TERTIARY CARE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL COMMUNITY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL COMMUNITY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL COMMUNITY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL SPECIALTY THORACIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL SPECIALTY THORACIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL SPECIALTY THORACIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY LUNG RESECTION, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ESOPHAGEAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MEDIASTINAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PLEURAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY CLOSURE & HEMOSTASIS PRODUCTS, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY IMAGING & NAVIGATION, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MALIGNANT THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRIMARY LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN ESOPHAGEAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY LUNG RESECTION, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ESOPHAGEAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MEDIASTINAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PLEURAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY CLOSURE & HEMOSTASIS PRODUCTS, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY IMAGING & NAVIGATION, 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MALIGNANT THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRIMARY LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 242. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 243. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN ESOPHAGEAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. NORTH AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 246. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 247. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY LUNG RESECTION, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ESOPHAGEAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MEDIASTINAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PLEURAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY CLOSURE & HEMOSTASIS PRODUCTS, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY IMAGING & NAVIGATION, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 260. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MALIGNANT THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 261. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRIMARY LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 262. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 263. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN ESOPHAGEAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 264. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 265. LATIN AMERICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 266. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 267. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 268. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY LUNG RESECTION, 2018-2032 (USD MILLION)
TABLE 269. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ESOPHAGEAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 270. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MEDIASTINAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 271. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PLEURAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 272. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 273. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 274. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 275. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 276. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 277. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY CLOSURE & HEMOSTASIS PRODUCTS, 2018-2032 (USD MILLION)
TABLE 278. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY IMAGING & NAVIGATION, 2018-2032 (USD MILLION)
TABLE 279. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 280. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MALIGNANT THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 281. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRIMARY LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 282. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 283. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN ESOPHAGEAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 284. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 285. EUROPE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 286. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 287. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 288. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY LUNG RESECTION, 2018-2032 (USD MILLION)
TABLE 289. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ESOPHAGEAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 290. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MEDIASTINAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 291. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PLEURAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 292. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 293. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 294. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 295. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 296. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 297. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY CLOSURE & HEMOSTASIS PRODUCTS, 2018-2032 (USD MILLION)
TABLE 298. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY IMAGING & NAVIGATION, 2018-2032 (USD MILLION)
TABLE 299. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 300. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MALIGNANT THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 301. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRIMARY LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 302. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 303. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN ESOPHAGEAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 304. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 305. MIDDLE EAST MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 306. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 307. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 308. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY LUNG RESECTION, 2018-2032 (USD MILLION)
TABLE 309. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ESOPHAGEAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 310. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MEDIASTINAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 311. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PLEURAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 312. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 313. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 314. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 315. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 316. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 317. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY CLOSURE & HEMOSTASIS PRODUCTS, 2018-2032 (USD MILLION)
TABLE 318. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY IMAGING & NAVIGATION, 2018-2032 (USD MILLION)
TABLE 319. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 320. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MALIGNANT THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 321. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PRIMARY LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 322. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN THORACIC DISEASES, 2018-2032 (USD MILLION)
TABLE 323. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY BENIGN ESOPHAGEAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 324. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 325. AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 326. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 327. ASEAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 328. ASEAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 329. ASEAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY LUNG RESECTION, 2018-2032 (USD MILLION)
TABLE 330. ASEAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ESOPHAGEAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 331. ASEAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MEDIASTINAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 332. ASEAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ

SELECT AN OPTION